What is Theralogix?
Theralogix distinguishes itself in the competitive nutritional supplement market through its unwavering commitment to high-quality, research-backed formulations. All products are NSF certified, ensuring a high standard of purity and efficacy. The company's extensive product line addresses various health needs, including fertility, prostate health, and general men's and women's wellness. With over two decades of operation, Theralogix has cultivated a reputation for transparency and ingredient integrity, earning the trust of healthcare providers and consumers alike. Their focus on scientifically validated and rigorously tested products positions them as a reliable source for health-conscious individuals.
How much funding has Theralogix raised?
Theralogix has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Theralogix
PPP
Public-Private Partnership
What's next for Theralogix?
The substantial large-scale, late-stage funding context suggests Theralogix is poised for significant expansion and market penetration. This strategic backing will likely fuel advancements in product development, enhance marketing initiatives, and potentially broaden distribution channels. The company's established track record and focus on quality provide a strong foundation for leveraging this new capital to further solidify its market leadership and explore new avenues for growth in the burgeoning health and wellness industry.
See full Theralogix company page
